Rising Antimicrobial Resistance Poses Critical Threat to Neurocritical Care Patients ~ Leading Neurocritical Care Experts Convened at the highly successful 7th Annual National Conference of the Society of Neurocritical Care of India (SNCC) on September 21-22, 2024, Mumbai to address the pressing need for novel anti-infective treatments in
The Indian pharmaceuticals sector is poised for robust revenue growth of 8-10% this fiscal year, building on last year's approximately 10% increase. This growth is attributed to strong exports to regulated markets, a rebound in semi-regulated markets, and consistent domestic demand.Improved Operating MarginsAs a result
Cipla Ltd. made headlines on Tuesday with a significant update regarding its board of directors. Mustafa Khwaja Hamied, commonly known as MK Hamied, will step down from his role as vice-chairman and non-executive director. The resignation will be effective at the close of business on
Entod Pharmaceuticals has announced that it has received final approval from the Drug Controller General of India (DCGI) for its groundbreaking PresVu eye drops. This approval, disclosed during a press conference held today in New Delhi, follows a favorable recommendation by the Subject Expert Committee
Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and innovation, today announced the appointment of Bharath Sesha as Managing Director for the Philips Indian subcontinent, effective September 1, 2024.In this role, Bharath will spearhead Philips' growth strategy in India, with a strong
Since July 2023 only 14 serious international complaints received , being future ready for coming winter season more than 8000 batches of cough syrup tested and only 2-3 per cent failures found The Central Drugs Standard Control Organization (CDSCO) announced a low failure rate of just
Lupin Limited announced on Thursday the launch of its generic cancer treatment drug in the US market. The Mumbai-based pharmaceutical firm has introduced Doxorubicin Hydrochloride Liposome Injection in single-dose vials.This launch follows the approval from the US Food and Drug Administration (FDA) received by Lupin’s
Aurelle Health, the country’s first D2C Nutraceutical brand aimed at revolutionizing Women’s Hormonal Health, has been launched in India. Aurelle Health’s debut marks a new landmark in the Indian nutraceutical space, with clean, authentic, natural and science-backed supplements based on thorough research and clinically-proven formulations.
“हारेगा डेंगू, हराएंगे हम” campaign launched to spread awareness regarding dengue prevention and controlThe United States Agency for International Development (USAID) and Takeda Biopharmaceuticals India Private Limited (formerly Baxalta Bioscience India Private Limited) have launched a new campaign called "Haarega Dengue Haraenge Hum (We
Gland Pharma Limited (Gland or Company), a generic injectable-focused pharmaceutical company, has received tentative approval from the United States Food and Drug Administration (USFDA) for Latanoprostene Bunod Ophthalmic Solution, 0.024%.The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Vyzulta® Ophthalmic Solution,
